These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
207 related items for PubMed ID: 1705237
1. Manipulation of intestinal immune responses against ovalbumin by cholera toxin and its B subunit in mice. Van der Heijden PJ, Bianchi AT, Dol M, Pals JW, Stok W, Bokhout BA. Immunology; 1991 Jan; 72(1):89-93. PubMed ID: 1705237 [Abstract] [Full Text] [Related]
2. Induction of an enteric Ig-response against ovalbumin and stimulation of the response by cholera toxin and its B-subunit in mice. Bianchi AT, Zwart RJ, Van der Heijden PJ. Reg Immunol; 1991 Jan; 3(3):131-8. PubMed ID: 2098068 [Abstract] [Full Text] [Related]
3. Enhancement of ovalbumin-specific IgA responses via oral boosting with antigen co-administered with an aqueous Solanum torvum extract. Israf DA, Lajis NH, Somchit MN, Sulaiman MR. Life Sci; 2004 Jun 11; 75(4):397-406. PubMed ID: 15147827 [Abstract] [Full Text] [Related]
4. Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant. Holmgren J, Czerkinsky C, Lycke N, Svennerholm AM. Am J Trop Med Hyg; 1994 Jun 11; 50(5 Suppl):42-54. PubMed ID: 8203723 [Abstract] [Full Text] [Related]
5. Modulation of oral tolerance to ovalbumin by cholera toxin and its B subunit. Pierre P, Denis O, Bazin H, Mbongolo Mbella E, Vaerman JP. Eur J Immunol; 1992 Dec 11; 22(12):3179-82. PubMed ID: 1446708 [Abstract] [Full Text] [Related]
6. Quantification of antigen-specific antibody-secreting cells in the small intestine and other lymphoid organs of mice after oral booster immunization. Van der Heijden PJ, Bianchi AT, Bokhout BA, Dol M, Scholten JW, Stok W. Immunology; 1989 Mar 11; 66(3):404-9. PubMed ID: 2467878 [Abstract] [Full Text] [Related]
7. Intranasal immunization with CTL epitope peptides from HIV-1 or ovalbumin and the mucosal adjuvant cholera toxin induces peptide-specific CTLs and protection against tumor development in vivo. Porgador A, Staats HF, Faiola B, Gilboa E, Palker TJ. J Immunol; 1997 Jan 15; 158(2):834-41. PubMed ID: 8993001 [Abstract] [Full Text] [Related]
8. Oral administration of cholera toxin-Sendai virus conjugate potentiates gut and respiratory immunity against Sendai virus. Liang XP, Lamm ME, Nedrud JG. J Immunol; 1988 Sep 01; 141(5):1495-501. PubMed ID: 2842395 [Abstract] [Full Text] [Related]
10. Sublingual tolerance induction with antigen conjugated to cholera toxin B subunit induces Foxp3+CD25+CD4+ regulatory T cells and suppresses delayed-type hypersensitivity reactions. Sun JB, Cuburu N, Blomquist M, Li BL, Czerkinsky C, Holmgren J. Scand J Immunol; 2006 Sep 01; 64(3):251-9. PubMed ID: 16918694 [Abstract] [Full Text] [Related]
11. Conversion of orally induced suppression of the mucosal immune response to ovalbumin into stimulation by conjugating ovalbumin to cholera toxin or its B subunit. Stok W, van der Heijden PJ, Bianchi AT. Vaccine; 1994 May 01; 12(6):521-6. PubMed ID: 8036826 [Abstract] [Full Text] [Related]
12. Mucosally induced immunological tolerance, regulatory T cells and the adjuvant effect by cholera toxin B subunit. Sun JB, Czerkinsky C, Holmgren J. Scand J Immunol; 2010 Jan 01; 71(1):1-11. PubMed ID: 20017804 [Abstract] [Full Text] [Related]
13. ADP-ribosylating bacterial enzymes for the targeted control of mucosal tolerance and immunity. Lycke N. Ann N Y Acad Sci; 2004 Dec 01; 1029():193-208. PubMed ID: 15681758 [Abstract] [Full Text] [Related]
14. Immunological tools for the assessment of both humoral and cellular immune responses in Foxes (Vulpes vulpes) using ovalbumin and cholera toxin B as an antigenic model. Rolland-Turner M, Farre G, Muller D, Rouet N, Boue F. Vaccine; 2004 Oct 22; 22(31-32):4163-72. PubMed ID: 15474706 [Abstract] [Full Text] [Related]
15. Sublingual 'oral tolerance' induction with antigen conjugated to cholera toxin B subunit generates regulatory T cells that induce apoptosis and depletion of effector T cells. Sun JB, Czerkinsky C, Holmgren J. Scand J Immunol; 2007 Oct 22; 66(2-3):278-86. PubMed ID: 17635805 [Abstract] [Full Text] [Related]
16. Transcutaneous immunization with cholera toxin B subunit adjuvant suppresses IgE antibody responses via selective induction of Th1 immune responses. Anjuère F, George-Chandy A, Audant F, Rousseau D, Holmgren J, Czerkinsky C. J Immunol; 2003 Feb 01; 170(3):1586-92. PubMed ID: 12538724 [Abstract] [Full Text] [Related]
17. Modulating dendritic cells to optimize mucosal immunization protocols. Williamson E, Westrich GM, Viney JL. J Immunol; 1999 Oct 01; 163(7):3668-75. PubMed ID: 10490961 [Abstract] [Full Text] [Related]
18. Cholera toxin and its B subunit promote dendritic cell vaccination with different influences on Th1 and Th2 development. Eriksson K, Fredriksson M, Nordström I, Holmgren J. Infect Immun; 2003 Apr 01; 71(4):1740-7. PubMed ID: 12654787 [Abstract] [Full Text] [Related]
19. A comparison of natural and recombinant cholera toxin B subunit as stimulatory factors in intranasal immunization. de Geus B, Dol-Bosman M, Scholten JW, Stok W, Bianchi A. Vaccine; 1997 Jul 01; 15(10):1110-3. PubMed ID: 9269054 [Abstract] [Full Text] [Related]
20. Intranasal immunization with an apolipoprotein B-100 fusion protein induces antigen-specific regulatory T cells and reduces atherosclerosis. Klingenberg R, Lebens M, Hermansson A, Fredrikson GN, Strodthoff D, Rudling M, Ketelhuth DF, Gerdes N, Holmgren J, Nilsson J, Hansson GK. Arterioscler Thromb Vasc Biol; 2010 May 01; 30(5):946-52. PubMed ID: 20167655 [Abstract] [Full Text] [Related] Page: [Next] [New Search]